• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket

    4/17/23 8:15:10 AM ET
    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BNGO alert in real time by email

    Gainers

    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.
    • Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) gained 106% to $1.36 in pre-market trading after Shin Nippon Biomedical Laboratories, Ltd.announced plans to acquire all outstanding shares of Satsuma for upfront cash consideration of $0.91 per share.
    • Prometheus Biosciences, Inc. (NASDAQ:RXDX) surged 70.1% to $193.93 in pre-market trading after Merck agreed to buy the company for $10.8 billion.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) climbed 47.1% to $6.31 in pre-market trading. Dragonfly Energy recently reported worse-than-expected Q4 sales results.
    • Oblong, Inc. (NASDAQ:OBLG) shares climbed 37.1% to $3.70 in pre-market trading after jumping 75% on Friday.
    • Presto Automation Inc. (NASDAQ:PRST) gained 35% to $1.89 in pre-market trading. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) gained 25.3% to $1.63 in pre-market trading after gaining more than 10% on Friday.
    • National CineMedia, Inc. (NASDAQ:NCMI) gained 22.1% to $0.4250 in pre-market trading after declining around 19% on Friday. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas.
    • RAPT Therapeutics, Inc. (NASDAQ:RAPT) climbed 19.3% to $20.00 in pre-market trading.
    • KWESST Micro Systems Inc. (NASDAQ:KWE) gained 17.7% to $3.07 in pre-market trading after gaining more than 17% on Friday.

    Losers

    • SAI.TECH Global Corporation (NASDAQ:SAI) fell 27.4% to $3.56 in pre-market trading after jumping 222% on Friday.
    • Marpai, Inc. (NASDAQ:MRAI) shares dropped 26.2% to $1.38 in pre-market trading after the company reported a proposed public offering of common stock.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 20.8% to $0.0570 in pre-market after dropping over 39% on Friday. The company recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
    • Near Intelligence, Inc. (NASDAQ:NIR) fell 19.2% to $4.82 in pre-market trading after surging 100% on Friday.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 17.1% to $1.74 in pre-market trading after dropping 7% on Friday.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 16% to $1.00 in pre-market trading. Regulus Therapeutics, last week, announced a $15 million private placement of equity.
    • CXApp Inc. (NASDAQ:CXAI) fell 15.2% to $11.75 in pre-market trading after jumping 94% on Friday.
    • Infobird Co., Ltd (NASDAQ:IFBD) fell 12.2% to $0.5020 in pre-market trading after gaining more than 19% on Friday. Infobird recently raised $5 million via a secondary share sale of 3.85 units at $1.30 per share.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 11.6% to $4.06 in pre-market trading after jumping 306% on Friday.
    • Bionano Genomics, Inc. (NASDAQ:BNGO) shares fell 11.1% to $0.9689 in pre-market trading after dropping 6% on Friday. Bionano announced presentation of OGM utility across cancer genomics research applications at the AACR.

    Now Read This: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying

    Get the next $BNGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNGO
    $CNSP
    $CXAI
    $DFLI

    CompanyDatePrice TargetRatingAnalyst
    RAPT Therapeutics Inc.
    $RAPT
    1/9/2026$95.00Overweight
    Piper Sandler
    National CineMedia Inc.
    $NCMI
    10/31/2025$7.00 → $6.50Outperform
    Barrington Research
    RAPT Therapeutics Inc.
    $RAPT
    10/27/2025$70.00Buy
    Guggenheim
    RAPT Therapeutics Inc.
    $RAPT
    10/20/2025$55.00Neutral → Overweight
    Analyst
    RAPT Therapeutics Inc.
    $RAPT
    10/13/2025$35.00Overweight
    Barclays
    RAPT Therapeutics Inc.
    $RAPT
    9/26/2025$37.00Market Perform → Outperform
    Leerink Partners
    RAPT Therapeutics Inc.
    $RAPT
    7/30/2025$14.00Underweight → Neutral
    Analyst
    RAPT Therapeutics Inc.
    $RAPT
    5/22/2025$6.00Buy
    H.C. Wainwright
    More analyst ratings

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on RAPT Therapeutics with a new price target

    Piper Sandler initiated coverage of RAPT Therapeutics with a rating of Overweight and set a new price target of $95.00

    1/9/26 9:07:04 AM ET
    $RAPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barrington Research reiterated coverage on National Cinemedia with a new price target

    Barrington Research reiterated coverage of National Cinemedia with a rating of Outperform and set a new price target of $6.50 from $7.00 previously

    10/31/25 7:55:49 AM ET
    $NCMI
    Advertising
    Consumer Discretionary

    Guggenheim initiated coverage on RAPT Therapeutics with a new price target

    Guggenheim initiated coverage of RAPT Therapeutics with a rating of Buy and set a new price target of $70.00

    10/27/25 8:48:35 AM ET
    $RAPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Financials

    Live finance-specific insights

    View All

    Dragonfly Energy to Report Preliminary Fourth Quarter and Full Year 2025 Financial and Operational Results on March 16, 2026

    RENO, Nev., March 13, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and battery technology, today announced that the Company will release its preliminary financial and operational results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, March 16, 2026. The earnings press release will be followed by a conference call on March 16, 2026, at 4:30 PM Eastern Time. Interested investors and other parties may access the live webcast via the link found here or through the Events and Presentations page within the Investor Relations section of Dragonfly Energ

    3/13/26 7:30:00 AM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

    SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Monday, March 23rd, 2026Time:4:30 p.m. ETParticipant Link:Registration – Click hereWebcast Link:Registration – Click here Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano's investor relations website at https://ir.biona

    3/9/26 4:05:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Leadership Updates

    Live Leadership Updates

    View All

    Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

    SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano's Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that could be the future of digital cytogenetics

    2/27/26 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Oblong Taps $TAO Expert Siam Kidd to Lead Strategic Advisory Committee and Accelerate Decentralized AI Expansion

    DSV Fund CIO joins to scale Oblong's $TAO treasury into the leading public vehicle for decentralized AI Kidd brings institutional expertise to unlock value across Bittensor's $1B+ AI subnet ecosystem and ignite next wave of growth Oblong (NASDAQ:OBLG), dedicated to advancing decentralized artificial intelligence through strategic treasury investments in Bittensor ($TAO), is thrilled to announce the formation of its Advisory Committee, with Siam Kidd appointed as its inaugural member. This milestone underscores Oblong's commitment to building a robust platform for investors seeking exposure to the rapidly growing decentralized AI ecosystem. Siam is a globally recognized crypto investo

    8/5/25 4:07:00 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lyons-Williams Lori closing all direct ownership in the company (SEC Form 4)

    4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)

    3/5/26 9:04:52 AM ET
    $RAPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gray Mary Ann closing all direct ownership in the company (SEC Form 4)

    4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)

    3/5/26 9:03:18 AM ET
    $RAPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Lesinski Thomas F. converted options into 49,706 shares and sold $110,426 worth of shares (31,106 units at $3.55), increasing direct ownership by 4% to 520,397 units (SEC Form 4)

    4 - National CineMedia, Inc. (0001377630) (Issuer)

    3/5/26 9:01:08 AM ET
    $NCMI
    Advertising
    Consumer Discretionary

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dragonfly Energy to Report Preliminary Fourth Quarter and Full Year 2025 Financial and Operational Results on March 16, 2026

    RENO, Nev., March 13, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and battery technology, today announced that the Company will release its preliminary financial and operational results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, March 16, 2026. The earnings press release will be followed by a conference call on March 16, 2026, at 4:30 PM Eastern Time. Interested investors and other parties may access the live webcast via the link found here or through the Events and Presentations page within the Investor Relations section of Dragonfly Energ

    3/13/26 7:30:00 AM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

    SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Monday, March 23rd, 2026Time:4:30 p.m. ETParticipant Link:Registration – Click hereWebcast Link:Registration – Click here Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano's investor relations website at https://ir.biona

    3/9/26 4:05:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives

    Marketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth OpportunityTAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of a transformational marketing agreement dramatically expanding the national reach of its high-growth pharmacy benefit management division, providing access to a network representing up to 1.5 million covered employees for MarpaiRx.The agreement creates a powerful new distribution channel for MarpaiRx's pharmacy benefit sol

    3/9/26 8:08:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Holst Peter bought $9,500 worth of shares (5,000 units at $1.90), increasing direct ownership by 47% to 15,544 units (SEC Form 4)

    4 - Oblong, Inc. (0000746210) (Issuer)

    11/19/25 3:15:50 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    President and CEO Holst Peter bought $18,400 worth of shares (10,000 units at $1.84), increasing direct ownership by 1,838% to 10,544 units (SEC Form 4)

    4 - Oblong, Inc. (0000746210) (Issuer)

    11/17/25 1:12:26 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    Director Schechter Jonathan bought $19,100 worth of shares (10,000 units at $1.91), increasing direct ownership by 67% to 25,000 units (SEC Form 4)

    4 - Oblong, Inc. (0000746210) (Issuer)

    11/17/25 1:11:43 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    SEC Filings

    View All

    CXApp Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - CXApp Inc. (0001820875) (Filer)

    3/12/26 9:00:41 AM ET
    $CXAI
    EDP Services
    Technology

    SEC Form 424B3 filed by CXApp Inc.

    424B3 - CXApp Inc. (0001820875) (Filer)

    3/12/26 9:00:41 AM ET
    $CXAI
    EDP Services
    Technology

    CNS Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CNS Pharmaceuticals, Inc. (0001729427) (Filer)

    3/11/26 8:35:29 AM ET
    $CNSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNGO
    $CNSP
    $CXAI
    $DFLI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dragonfly Energy Holdings Corp.

    SC 13D/A - Dragonfly Energy Holdings Corp. (0001847986) (Subject)

    11/21/24 6:10:38 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by National CineMedia Inc.

    SC 13D/A - National CineMedia, Inc. (0001377630) (Subject)

    11/20/24 9:34:56 PM ET
    $NCMI
    Advertising
    Consumer Discretionary